Aura Biosciences: Mid-2024 Data Could Bring Expansion Opportunity
Seeking Alpha,
Summary Results from the phase 1 trial, using bel-sar to treat patients with bladder cancer, expected in mid-2024.
Summary Results from the phase 1 trial, using bel-sar to treat patients with bladder cancer, expected in mid-2024.
Uveal melanomais a rare type of cancer that grows in the melanin, the dark-colored pigment of the eye.
Uveal melanomais a rare type of cancer that grows in the melanin, the dark-colored pigment of the eye.
Uveal melanomais a rare type of cancer that grows in the melanin, the dark-colored pigment of the eye.